NCT06535360View on ClinicalTrials.gov

Efficacy of Pathogen Inactivation Strategies for Platelet Transfusion

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

May 31, 2023

Study Completion Date

May 31, 2023

Conditions
Cardiopulmonary Bypass Surgery
Interventions
BIOLOGICAL

Platelet transfusion

platelet administration through intravenous access

Trial Locations (1)

21201

University of Maryland Medical Center, Baltimore

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER

NCT06535360 - Efficacy of Pathogen Inactivation Strategies for Platelet Transfusion | Biotech Hunter | Biotech Hunter